Importantly, we found that CDK5RAP3 was a significant regulator of GSK3β phosphorylation in gastric cancer, leading to the subsequent degradation of β-catenin and influencing the prognosis of gastric cancer patients. This evidence concerns the gene CDK5RAP3 and gastric cancer.